Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Suzuki Pharmaceutical was a pioneering Japanese chemical/pharmaceutical company established in 1893–1907 by Saburosuke Suzuki II. It became known for extracting iodine from seaweed and later played a pivotal role in commercializing monosodium glutamate (MSG) after collaborating with Dr. Kikunae Ikeda—leading directly to the founding of Ajinomoto Co., Inc.[1][2][8]. The company's pharmaceutical activities included early exports of iodine and saltpeter but did not survive independently past the early 20th century due to market changes and mergers. Its legacy lives on primarily through Ajinomoto's global food science/pharma business.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Suzuki Pharmaceutical.